Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole Combined With Cyclosporine A in Subclinical PNH and BMF
NCT01760096Phase 2Unknown
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Jan 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of levamisole in paroxysmal nocturnal hemoglobinuria (PNH), bone marrow failure and aplastic anemia (3 arms), sponsored by Institute of Hematology and Blood Diseases Hospital. Primary endpoint: Number of patients in each group in complete or partial remission at 6 months. Status: unknown.
02
Drugs
levamisole
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)bone marrow failureaplastic anemia
Beyond the preview
Go deeper on NCT01760096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01760096.